The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Open accessAbstract
Soluble oligomers of amyloid beta (Abeta) play a role in the memory impairment characteristic of Alzheimer's disease. Acting as pathogenic ligands, Abeta oligomers bind to particular synapses and perturb their function, morphology, and maintenance. Events that occur shortly after oligomer binding have been investigated here in live hippocampal neurons by single particle tracking of quantum dot-labeled oligomers and synaptic proteins. Membrane-attached oligomers initially move freely, but their diffusion is hindered markedly upon accumulation at synapses. Concomitantly, individual metabotropic glutamate receptors (mGluR5) manifest strikingly reduced lateral diffusion as they become aberrantly clustered. This clustering of mGluR5 elevates intracellular calcium and causes synapse deterioration, responses prevented by an mGluR5 antagonist. As expected, clustering by artificial crosslinking also promotes synaptotoxicity. These results reveal a mechanism whereby Abeta oligomers induce the abnormal accumulation and overstabilization of a glutamate receptor, thus providing a mechanistic and molecular basis for Abeta oligomer-induced early synaptic failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Aβ oligomers can drive additional vicious cycles by stimulating metabotropic glutamate receptor 5 (mGluR5)146,147, which activates feedforward Ca2+–cAMP signaling and drive tau phosphorylation (Fig. 5, brown).”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [146]
In the citing paper
“Aβ binds to α7 nicotinic acetylcholine receptors (α7 nAChRs) and to metabotropic glutamate receptors, in particular mGluR5 [31–33].”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [32]
In the citing paper
“ADDL binding to synapses displays saturable kinetics (Renner et al., 2010)”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“Double-labeling with synaptophysin or FM463 establishes this localization to be at functional synapses (Renner et al., 2010).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“single particle tracking of quantum dot-labeled Aβ oligomers has demonstrated the participation of metabotropic glutamate receptors (mGluR5) in oligomer binding and clustering at synapses (Renner et al., 2010).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“Initially, Aβ oligomers diffused as if bound to an untethered protein. Within minutes, however, movement slowed and oligomers became immobilized, typically at active synapses labeled with FM4-64. The synaptic trapping of oligomers was accompanied by co-clustering and immobilization of mGluR5 metabotropic glutamate receptors.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“protection also is afforded by antagonists of metabotropic mGluR5 receptors (Rammes et al., 2011; Renner et al., 2010; Wang et al., 2004).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“the recent finding that mGluR5 is implicated in the toxic clustering of Aβ oligomers at synapses and the ensuing aberrant calcium signaling (Renner et al., 2010) suggests that selective mGluR5 inhibitors may hold potential to block oligomer-induced synapse dysfunction.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Diffusion Dynamics of Glycine Receptors Revealed by Single-Quantum Dot Tracking
Dahan, M., Lévi, S., Luccardini, C., Rostaing, P., Riveau, B., & Triller, A. (2003) · Science · doi:10.1126/science.1088525 · Cited by 1,465
Self-citationAstrocyte Control of Synaptic Transmission and Neurovascular Coupling
Haydon, P. G., & Carmignoto, G. (2006) · Physiological Reviews · doi:10.1152/physrev.00049.2005 · Cited by 1,371
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Self-citation
Cited by
Sorted by citations
Items 201–300 of 468
Kempf, S. J., Janik, D., Barjaktarović, Ž., Braga-Tanaka, I., Tanaka, S., Neff, F., Saran, A., Larsen, M. R., & Tapio, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12376 · Cited by 47
González-Sanmiguel, J., Schuh, C. M. A. P., Muñoz-Montesino, C., Contreras‐Kallens, P., Aguayo, L. G., & Aguayo, S. D. (2020) · Cells · doi:10.3390/cells9112476 · Cited by 50
Bodzęta, A., Scheefhals, N., & MacGillavry, H. D. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108799 · Cited by 49
NMDA receptors and BAX are essential for Aβ impairment of LTP
Olsen, K. M., & Sheng, M. (2012) · Scientific Reports · doi:10.1038/srep00225 · Cited by 47
DeLorenzo, C., Sóvágó, J., Gardus, J. D., Xu, J., Yang, J., Behrje, R., Kumar, J. S. D., Devanand, D. P., Pelton, G. H., Mathis, C. A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.189 · Cited by 44
Self-citationNovel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism
Westmark, C. J., Sokol, D. K., Maloney, B., & Lahiri, D. K. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.134 · Cited by 45
Guglietti, B., Sivasankar, S., Mustafa, S., Corrigan, F., & Collins‐Praino, L. E. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02518-3 · Cited by 48
Long-term dynamics of aberrant neuronal activity in awake Alzheimer’s disease transgenic mice
Korzhova, V., Marinković, P., Njavro, J. R., Goltstein, P. M., Sun, F., Tahirović, S., Herms, J. W., & Liebscher, S. (2021) · Communications Biology · doi:10.1038/s42003-021-02884-7 · Cited by 51
mGluR5 is transiently confined in perisynaptic nanodomains to shape synaptic function
Scheefhals, N., Westra, M., & MacGillavry, H. D. (2023) · Nature Communications · doi:10.1038/s41467-022-35680-w · Cited by 43
Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases
Joly‐Amado, A., Kulkarni, N., & Nash, K. R. (2023) · Brain Sciences · doi:10.3390/brainsci13101479 · Cited by 47
Glimepiride protects neurons against amyloid-β-induced synapse damage
Osborne, C., West, E., Nolan, W., McHale-Owen, H., Williams, A., & Bate, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.030 · Cited by 43
Morkūnienė, R., Čižas, P., Jankevičiūtė, S., Petrolis, R., Arandarčikaitė, O., Kriščiukaitis, A., & Borutaitė, V. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23510 · Cited by 44
M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer’s disease pathology
Yi, J. H., Whitcomb, D. J., Park, S. J., Martinez-Perez, C., Barbati, S. A., Mitchell, S. J., & Cho, K. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa058 · Cited by 41
Hoque, A., Hossain, M. I., Ameen, S. S., Ang, C., Williamson, N. A., Ng, D. C. H., Chüeh, A. C., Roulston, C. L., & Cheng, H. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.009 · Cited by 42
A glycine zipper motif mediates the formation of toxic β-amyloid oligomers in vitro and in vivo
Fonte, V. G., Dostal, V., Roberts, C. M., Gonzales, P. K., Lacor, P. N., Magrané, J., Dingwell, N., Fan, E. Y., Silverman, M. A., Stein, G. H., et al. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-61 · Cited by 37
Self-citationMicroglia degrade Alzheimer’s amyloid-beta deposits extracellularly via digestive exophagy
Jacquet, R. G., González Ibáñez, F., Picard, K., Funes, L., Khakpour, M., Gouras, G. K., Tremblay, M.-È., Maxfield, F. R., & Solé-Domènech, S. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115052 · Cited by 42
Boehm, J. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12251 · Cited by 41
Partitioning and confinement of GM1 ganglioside induced by amyloid aggregates
Calamai, M., & Pavone, F. S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.03.014 · Cited by 39
Raka, F., Sebastiano, A. R. D., Kulhawy, S. C., Ribeiro, F. M., Godin, C. M., Caetano, F. A., Angers, S., & Ferguson, S. S. G. (2015) · Molecular Brain · doi:10.1186/s13041-015-0111-4 · Cited by 39
Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
Milisav, I., Šuput, D., & Ribarič, S. (2015) · Molecules · doi:10.3390/molecules201219865 · Cited by 42
The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Brouillette, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990498 · Cited by 39
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease
Abd‐Elrahman, K. S., Sarasija, S., & Ferguson, S. S. G. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210916102638 · Cited by 39
Ostapchenko, V. G., Beraldo, F. H., Guimarães, A. L. S., Mishra, S., Guzmán, M. S., Fan, J., Martins, V. R., Prado, V. F., & Prado, M. A. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12296 · Cited by 38
Budgett, R. F., Bakker, G., Sergeev, E., Bennett, K. A., & Bradley, S. J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.893422 · Cited by 38
mGluR5 mediates post-radiotherapy fatigue development in cancer patients
Feng, L., Fernández‐Martínez, J. L., Zaal, K. J. M., deAndrés‐Galiana, E. J., Wolff, B. S., & Saligan, L. N. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0161-3 · Cited by 37
Lee, J., Cho, E., Kwon, H., Jeon, J., Jung, C. J., Moon, M., Jun, M., Lee, Y. C., Kim, D. H., & Jung, J. W. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112107 · Cited by 37
Calamai, M., & Pavone, F. S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200951f · Cited by 38
Aß Facilitates LTD at Schaffer Collateral Synapses Preferentially in the Left Hippocampus
O’Riordan, K. J., Hu, N., & Rowan, M. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.085 · Cited by 35
Sathe, G. J., Mangalaparthi, K. K., Jain, A., Darrow, J. A., Troncoso, J. C., Albert, M., Moghekar, A., & Pandey, A. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0191 · Cited by 34
Majumder, P., Chanda, K., Das, D., Singh, B. K., Chakrabarti, P., Jana, N. R., & Mukhopadhyay, D. (2021) · Biochemical Journal · doi:10.1042/bcj20210175 · Cited by 38
Wang, J., He, Y., Chen, X., Huang, L., Li, J., You, Z., Huang, Q., Ren, S., He, K., Schibli, R., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01385-z · Cited by 39
Chen, H., Yan, G., Wen, M., Brooks, K. N., Zhang, Y., Huang, P.-S., & Chen, T. (2024) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.4c00019 · Cited by 34
Wilcox, K. C., Marunde, M. R., Das, A., Velasco, P. T., Kuhns, B. D., Marty, M. T., Haoming, J., Luan, C.-H., Sligar, S. G., & Klein, W. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125263 · Cited by 37
Self-citationSingle-Molecule Imaging Reveals Aβ42:Aβ40 Ratio-Dependent Oligomer Growth on Neuronal Processes
Johnson, R. D., Schauerte, J. A., Chang, C.-C., Wisser, K. C., Althaus, J. C., Carruthers, C. J. L., Sutton, M. A., Steel, D. G., & Gafni, A. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.12.051 · Cited by 34
Age dependency of mGluR5 availability in 5xFAD mice measured by PET
Lee, M., Lee, H., Jeong, Y. J., Oh, S. J., Kang, K. J., Han, S. J., Nam, K. R., Lee, Y. J., Lee, K. C., Ryu, Y. H., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.006 · Cited by 33
Bellozi, P. M. Q., Gomes, G. F., da Silva, M. C. M., Lima, I. V. D. A., Batista, C. R. Á., Carneiro, W. D. O., Doria, J. G., Vieira, É. L. M., Vieira, R. P., de Freitas, R. P., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107785 · Cited by 34
Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
Wilson, H., Politis, M., Rabiner, E. A., & Middleton, L. T. (2020) · Cells · doi:10.3390/cells9122581 · Cited by 34
Abd‐Elrahman, K. S., Sarasija, S., Colson, T. L., & Ferguson, S. S. G. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15750 · Cited by 34
Linsenmeier, L., Mohammadi, B., Shafiq, M., Frontzek, K., Bär, J., Shrivastava, A. N., Daμμe, M., Song, F., Schwarz, A., Vela, S. D., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj1826 · Cited by 34
Self-citationLane, R. F., Shineman, D. W., Steele, J., Lee, L. H., & Fillit, H. M. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00007-6 · Cited by 35
Kohno, M., Horibe, T., Ohara, K., Ito, S., & Kawakami, K. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.008 · Cited by 33
Ribeiro, F. C., Cozachenco, D., Heimfarth, L., Fortuna, J. T. S., de Freitas, G. B., de Sousa, J. M., Alves‐Leon, S. V., Leite, R. E. P., Suemoto, C. K., Grinberg, L. T., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05511-9 · Cited by 34
Fang, X. T., Eriksson, J., Antoni, G., Yngve, U., Cato, L., Lannfelt, L., Sehlin, D., & Syvänen, S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.009 · Cited by 31
Liang, J., Kulasiri, D., & Samarasinghe, S. (2015) · Biosystems · doi:10.1016/j.biosystems.2015.05.003 · Cited by 33
Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease
Александровна, П. Е., Chernyuk, D., & Борисович, Б. И. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200528162046 · Cited by 34
Kalweit, A. N., Yang, H., Colitti-Klausnitzer, J., Fülöp, L., BozsÃ, Z., Penke, B., & Manahan‐Vaughan, D. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00103 · Cited by 34
Neurogranin restores amyloid β-mediated synaptic transmission and long-term potentiation deficits
Kaleka, K. S., & Gerges, N. Z. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.12.013 · Cited by 33
Rammes, G., Mattusch, C., Wulff, M., Seeser, F., Kreuzer, M., Zhu, K., Deussing, J. M., Herms, J. W., & Parsons, C. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.003 · Cited by 37
Dynamic micro-organization of P2X7 receptors revealed by PALM based single particle tracking
Shrivastava, A. N., Rodriguez, P. C., Triller, A., & Renner, M. L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00232 · Cited by 32
Self-citationWang, X., Kastanenka, K. V., Arbel‐Ornath, M., Commins, C., Kuzuya, A., Lariviere, A., Krafft, G. A., Hefti, F. F., Jerecìć, J., & Bacskai, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22979-2 · Cited by 32
Natural Amyloid-Beta Oligomers Acutely Impair the Formation of a Contextual Fear Memory in Mice
Kittelberger, K. A., Piazza, F., Tesco, G., & Reijmers, L. G. J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029940 · Cited by 35
Canet, G., Zussy, C., Hernandez, C., Maurice, T., Desrumaux, C. M., & Givalois, L. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108398 · Cited by 34
Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer
Lee, M., Lee, H., Park, I. S., Park, J. A., Kwon, Y., Ryu, Y. H., Kim, C. H., Kang, J. H., Hyun, I. Y., Lee, K. C., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.003 · Cited by 30
Fragile X and APP: a Decade in Review, a Vision for the Future
Westmark, C. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1344-x · Cited by 31
Kinase Signaling in Dendritic Development and Disease
Nourbakhsh, K., & Yadav, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.624648 · Cited by 31
The Role of Synaptopodin in Membrane Protein Diffusion in the Dendritic Spine Neck
Wang, L., Dumoulin, A., Renner, M. L., Triller, A., & Specht, C. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148310 · Cited by 29
Self-citationCernescu, M., Stark, T., Kalden, E., Kurz, C., Leuner, K., Deller, T., Göbel, M., Eckert, G. P., & Brutschy, B. (2012) · Analytical Chemistry · doi:10.1021/ac300258m · Cited by 30
Zhang, D., Qi, Y., Klyubin, I. V., Ondrejčák, T., Sarell, C. J., Cuello, A. C., Collinge, J., & Rowan, M. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.036 · Cited by 32
Rammes, G., Seeser, F., Mattusch, K., Zhu, K., Haas, L. T., Kummer, M. P., Heneka, M. T., Herms, J. W., & Parsons, C. G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.021 · Cited by 30
Family C G-Protein-Coupled Receptors in Alzheimer’s Disease and Therapeutic Implications
Prà, I. D., Armato, U., & Chiarini, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01282 · Cited by 31
Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease
Ganeshpurkar, A., Swetha, R., Kumar, D., Gangaram, G. P., Singh, R., Gutti, G., Jana, S., Kumar, D., Kumar, A., & Singh, S. K. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190304153353 · Cited by 30
Single-cell and spatial detection of senescent cells using DeepScence
Qu, Y., Ji, B., Dong, R., Gu, L., Chan, C., Xie, J., Glass, C., Wang, X.-F., Nixon, A. B., & Ji, Z. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.101035 · Cited by 30
Dinamarca, M. C., Luca, M. D., Godoy, J. A., & Inestrosa, N. C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.107 · Cited by 32
Synaptic Alterations in Mouse Models for Alzheimer Disease—A Special Focus on N-Truncated Abeta 4-42
Dietrich, K., Bouter, Y., Müller, M., & Bayer, T. A. (2018) · Molecules · doi:10.3390/molecules23040718 · Cited by 30
Wang, Z.-J., Zhao, F., Wang, C.-F., Zhang, X., Xiao, Y., Zhou, F., Wu, M., Zhang, J., Qi, J., & Yang, W. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190796 · Cited by 30
Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer’s Disease
Samant, N. P., & Gupta, G. L. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00467-2 · Cited by 30
Johnson, R. D., Steel, D. G., & Gafni, A. (2014) · Protein Science · doi:10.1002/pro.2479 · Cited by 29
Interactions of amyloid-β peptides on lipid bilayer studied by single molecule imaging and tracking
Chang, C., Edwald, E., Veatch, S. L., Steel, D. G., & Gafni, A. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.017 · Cited by 31
Ullah, G., Demuro, A., Parker, I., & Pearson, J. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137357 · Cited by 30
Protein aggregation and prionopathies
Renner, M. L., & Melki, R. (2014) · Pathologie Biologie · doi:10.1016/j.patbio.2014.01.003 · Cited by 31
Self-citationThe Role of Synaptic Dysfunction in Alzheimer’s Disease
Pei, Y. A., Davies, J., Zhang, M., & Zhang, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191334 · Cited by 29
Liang, Y., Raven, F., Ward, J. F., Zhen, S. Y., Zhang, S., Sun, H., Miller, S., Choi, S. H., Tanzi, R. E., & Zhang, C. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200128 · Cited by 29
Li, W., Marta Kutas, A., Gray, J. A., Hagerman, R. J., & Olichney, J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.023 · Cited by 27
Epelbaum, S., Youssef, I., Lacor, P. N., Chaurand, P., Duplus, E., Brugg, B., Duyckaerts, C. J., & Delatour, B. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.005 · Cited by 30
Self-citationWillén, K. I., Sroka-Oleksiak, A., Takahashi, R. H., & Gouras, G. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170262 · Cited by 28
Role of ASIC1a in Aβ-induced synaptic alterations in the hippocampus
Mango, D., & Nisticò, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.016 · Cited by 27
Wang, J., Huang, Q., He, K., Li, J., Guo, T., Yang, Y., Lin, Z., Li, S., Vanderlinden, G., Huang, Y. H., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13817 · Cited by 26
Treyer, V., Gietl, A. F., Suliman, H., Gruber, E., Meyer, R., Buchmann, A., Johayem, A., Unschuld, P. G., Nitsch, R. M., Buck, A., et al. (2020) · Brain and Behavior · doi:10.1002/brb3.1632 · Cited by 25
β-amyloid oligomers and prion protein
Forloni, G., & Balducci, C. (2011) · Prion · doi:10.4161/pri.5.1.14367 · Cited by 26
The Transcription Factor XBP1 in Memory and Cognition: implications in Alzheimer’s Disease
Cissé, M., Duplan, E., & Checler, F. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00229 · Cited by 28
Lee, K., Vyas, Y., Garner, C. C., & Montgomery, J. M. (2019) · Synapse · doi:10.1002/syn.22097 · Cited by 28
Intraneuronally injected amyloid beta inhibits long-term potentiation in rat hippocampal slices
Nomura, I., Takechi, H., & Kato, N. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00589.2011 · Cited by 27
The transcriptional landscape of Alzheimer’s disease and its association with Wnt signaling pathway
Martínez, M., & Inestrosa, N. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.029 · Cited by 26
Structural and mechanistic commonalities of amyloid-β and the prion protein
Dias, B. D. C., Jovanovic, K., Gonsalves, D., & Weiss, S. F. T. (2011) · Prion · doi:10.4161/pri.5.3.17025 · Cited by 28
Rubel, A. A., Belashova, T. A., Antonets, K. S., Chernoff, Y. O., & Galkin, A. P. (2013) · Prion · doi:10.4161/pri.26867 · Cited by 27
Johnson, J. T., Fila, W. A., & Anumudu, C. K. (2025) · Applied Sciences · doi:10.3390/app151810285 · Cited by 29
Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
Loh, D., & Reiter, R. J. (2022) · Molecules · doi:10.3390/molecules27030705 · Cited by 25
Single particle tracking of acyl carrier protein (ACP)-tagged TrkA receptors in PC12nnr5 cells
Callegari, A., Luin, S., Marchetti, L., Duci, A., Cattaneo, A., & Beltram, F. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.10.019 · Cited by 25
Calamai, M., Evangelisti, E., Cascella, R., Parenti, N., Cecchi, C., Stefani, M., & Pavone, F. S. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.12.009 · Cited by 27
DiChiara, T., DiNunno, N., Clark, J. R., Bu, R. L., Cline, E. N., Rollins, M. G., Gong, Y., Brody, D. L., Sligar, S. G., Velasco, P. T., et al. (2017) · PubMed · Cited by 25
Self-citationFyn Kinase in Alzheimer’s Disease: Unraveling Molecular Mechanisms and Therapeutic Implications
Meur, S., & Karati, D. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04286-2 · Cited by 24
Melatonin in Synaptic Impairments of Alzheimer’s Disease
Shi, Y., Fang, Y., Wei, Y., Jiang, Q., Zeng, P. H., Tang, N., Lu, Y., & Tian, Q. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171178 · Cited by 24
Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative Diseases
Khotimchenko, Y. S., Silachev, D. N., & Katanaev, V. L. (2022) · Marine Drugs · doi:10.3390/md20110708 · Cited by 25
Kroker, K. S., Moreth, J., Kußmaul, L., Rast, G. F., & Rosenbrock, H. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.04.006 · Cited by 24
APP Causes Hyperexcitability in Fragile X Mice
Westmark, C. J., Chuang, S.-C., Hays, S. A., Filon, M. J., Ray, B. C., Westmark, P. R., Gibson, J. R., Huber, K. M., & Wong, R. K. S. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00147 · Cited by 24
Diversity of Metabotropic Glutamate Receptor–Interacting Proteins and Pathophysiological Functions
Fagni, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_3 · Cited by 24
Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer’s Disease
Zhang, X., Lao, K., Qiu, Z., Rahman, M. S., Zhang, Y., & Gou, X. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181084 · Cited by 24
Liu, L., Gao, H., Zaikin, A. A., & Chen, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.767892 · Cited by 23
Labeling of neuronal receptors and transporters with quantum dots
Chang, J. C., Kovtun, O., Blakely, R., & Rosenthal, S. J. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1186 · Cited by 22
Metadata
- Authors
- Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Northwestern University (US)
- Corresponding author
- Klein, William L.
- Triller, Antoine
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 66
- Issue
- 5
- Pages
- 739-754
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC3111138
- OpenAlex
- W2003655335
- Cited by
- 468
- References
- 62
- Citations by year
- 2026: 18 · 2025: 22 · 2024: 23 · 2023: 14 · 2022: 26 · 2021: 34 · 2020: 38 · 2019: 25 · 2018: 29 · 2017: 26 · 2016: 32 · 2015: 38 · 2014: 31 · 2013: 30 · 2012: 44
- FWCI
- 24.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, cc-by-nc)
- Funders
- National Institute on Aging (R01AG029460)
- National Institute of Neurological Disorders and Stroke (R01NS058894)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, mGluR5, metabotropic glutamate receptors, receptor clustering, synaptic dysfunction, synaptotoxicity, Alzheimer's disease, hippocampal neurons, single-particle tracking, quantum dots, intracellular calcium, receptor diffusion, receptor cross-linking
- MeSH terms
- Animals, Cells, Cultured, Extracellular Matrix, Neurons, Protein Binding, Synapses, Amyloid beta-Peptides, Rats, Sprague-Dawley, Receptors, Metabotropic Glutamate, Mice, Knockout, Mice, Rats, Protein Stability, Receptor, Metabotropic Glutamate 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
